Suggestions
Guide for authors
Searcher
Brazilian Journal of Otorhinolaryngology (English Edition)
Brazilian Journal of Otorhinolaryngology (English Edition)
ISSN: 1808-8694

Official Publication of the Brazilian Association of Otorhinolaryngology and Cervicofacial Surgery (ABORL-CCF). The Brazilian Journal of Otorhinolaryngology: Neck and Head Surgery aims to provide timely information for physicians and scientists focused on otorhinolaryngology and head and neck disorders, including contemporary, ethical, clinically relevant information in:

- General otolaryngology;
- Head and neck surgery;
- Respiratory sleep disorders;
- Allergy/rhinology;
- Otology/neurotology;
- Laryngology/broncho-esophagology;
- Pediatric otolaryngology;
- Cranio-facial surgery;
- Skull base surgery;
- Head and neck oncology;
- Phoniatrics;
- Upper airway related diseases;
- Facial plastics and reconstructive surgery.

The journal is the official peer-reviewed open access scientific publication of the Brazilian Association of Otorhinolaryngology and Cervicofacial Surgery (ABORL-CCF).

All articles will be published under the CC-BY license (Creative Commons Attribution 4.0 International) with copyright owned by the ABORL-CCF.

See more

Please note that articles submitted as of May 1, 2022, which are accepted for publication will be subject to a fee (Article Publishing Charge, APC) payment by the author or research funder to cover the costs associated with publication.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), SCImago Journal Rank (SJR), SNIP, SciELO - Scientific Electronic Library Online, Science Citation Index Expanded (SCIE)

See more
Follow us:
Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more
Impact factor 2024
1.8
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2024
3.2
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2024
0.551
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2024
1.138
Time to first decision

The median number of days it takes for an article to go from submission to first editorial decision.

See more
Time to first decision
62 days
View more metrics
Hide
Last published articles
Editorial
Moving past the usual suspects: a new framework for aural fullness
Roseli Saraiva Moreira Bittar, Lucas Resende Lucinda Mangia, Raquel Mezzalira
Braz J Otorhinolaryngol. 2026;92:
Full text access
Case report
Lipoma in the hypopharynx: a case report
Diego Guzman Rodrigues, Rynat Dasaev Oliveira Chagas, Natália Matos Muricy, Raissa Damasceno Barreto da Silva
Braz J Otorhinolaryngol. 2026;92:
Full text access
Review article
Efficacy and safety of corticosteroids in the management of chronic rhinosinusitis: A systematic review and meta-analysis of randomized and non-randomized studies
BinBin Wang, Feng Liu, Bo Wei
Braz J Otorhinolaryngol. 2026;92:
Highlights

  • Corticosteroids reduce SNOT-22 scores by 16 points in CRS.

  • Endoscopic outcomes improve significantly with corticosteroid use.

  • Local therapy cuts systemic steroid dependence by 70%.

  • No increased risk of serious adverse events observed.

Full text access
Review article
The emerging role of anti-thymic stromal lymphopoietin monoclonal antibody (Tezepelumab) in comorbid and non-comorbid CRSwNP patients: a scoping review
Antonio Moffa, Eugenio de Corso, Domiziana Nardelli, Antonella Loperfido, Jacopo Galli, Peter Baptista, Manuele Casale
Braz J Otorhinolaryngol. 2026;92:
Highlights

  • Tezepelumab improves CRSwNP symptoms and polyp burden.

  • Tezepelumab reduces nasal congestion and loss of smell in CRSwNP.

  • Tezepelumab is effective in patients with CRSwNP and comorbid asthma.

  • Tezepelumab lowers systemic corticosteroid and surgical needs.

  • Tezepelumab targets upstream inflammation, including T2 and non-T2 types.

Full text access
Latest issue
Issue
Cover Vol. 92. Issue 3. (In progress)Vol. 92. Issue 3. (In progress)
(May - June 2026)
This issue is in progress but contains articles that are final and fully citable.
Editorials
Moving past the usual suspects: a new framework for aural fullness
Roseli Saraiva Moreira Bittar, Lucas Resende Lucinda Mangia, Raquel Mezzalira
Braz J Otorhinolaryngol. 2026;92:
Full text access
Case reports
Lipoma in the hypopharynx: a case report
Diego Guzman Rodrigues, Rynat Dasaev Oliveira Chagas, Natália Matos Muricy, Raissa Damasceno Barreto da Silva
Braz J Otorhinolaryngol. 2026;92:
Full text access
View latest issue View all issues
Editorial Board
Carlos Takahiro Chone
Carlos Takahiro Chone, MD, PhD
Universidade Estadual de Campinas, CAMPINAS, Brazil
View editorial board
All issues
portada-Vol. 92. Issue 3. (In progress)
May - June
Volume 92 . Issue. 3
In progress
portada-Vol. 92. Issue 2. (In progress)
March - April
Volume 92 . Issue. 2
In progress
portada-Vol. 92. Issue 1.
January - February
Volume 92 . Issue. 1
portada-Vol. 91. Issue 6.
November - December
Volume 91 . Issue. 6
View all issues
Supplements
portada-Vol. 91. Issue  S1.
July
Volume 91. Issue. S1
Special Issue dedicated to Archives of Head and Neck Surgery
portada-Vol. 88. Issue  S5.
November - December
Volume 88. Issue. S5
Pages S1-S206
portada-Vol. 88. Issue  S4.
November - December
Volume 88. Issue. S4
Pages S1-S230
portada-Vol. 88. Issue  S3.
November - December
Volume 88. Issue. S3
Pages S1-S234
View all supplements
Instructions for authors
Publish in Brazilian Journal of Otorhinolaryngology (English Edition)
Most often read
Editorial
Alexandre Vallée
10.1016/j.bjorl.2025.101714
Braz J Otorhinolaryngol. 2026;92:
This article has been read 1.888 times
View all Most Often read articles
Brazilian Journal of Otorhinolaryngology (English Edition)
Announcement Nota importante
Articles submitted as of May 1, 2022, which are accepted for publication will be subject to a fee (Article Publishing Charge, APC) payment by the author or research funder to cover the costs associated with publication. By submitting the manuscript to this journal, the authors agree to these terms. All manuscripts must be submitted in English.. Os artigos submetidos a partir de 1º de maio de 2022, que forem aceitos para publicação estarão sujeitos a uma taxa (Article Publishing Charge, APC) a ser paga pelo autor para cobrir os custos associados à publicação. Ao submeterem o manuscrito a esta revista, os autores concordam com esses termos. Todos os manuscritos devem ser submetidos em inglês.